Three more biotechnology companies went public Thursday as startups continued to capitalize on strong demand for these offerings, a trend that’s giving life-sciences venture capitalists a much-needed lift.
John Guillemin/Bloomberg News Cellular Dynamics International Inc., Conatus Pharmaceuticals Inc. and Onconova Therapeutics Inc. debuted on Nasdaq Thursday. Their initial public offerings followed recent IPOs from venture-backed biotechs such as Agios Pharmaceuticals Inc., bluebird bio Inc., Esperion Therapeutics Inc., OncoMed Pharmaceuticals Inc. and Prosensa Holding BV.
Image: John Guillemin/Bloomberg News
To read the full, original article click on this link: Three More Biotechs Go Public as Surging IPO Market Lifts Life-Sciences VCs - Venture Capital Dispatch - WSJ
